Spoštovani kupci!
Zaradi prenove spletne strani in prehoda na OJS spletna prodaja trenutno ne dela. Prosim, če sporočite, kaj bi radi kupili, na prodaja@medrazgl.si. Dopišite vaše ime in priimek, naslov ter način plačila (s predračunom, ob povzetju ali z gotovino, če prezvamete gradivo v živo v prostorih uredištva v času uradnih ur).
Hvala za razumevanje!
MENU
Anatomy
Anesthesiology
Biochemistry
Biomedical Informatics
Biophysics
Cell Biology
Clinical Cases
Dentistry
Dermatovenerology
Emergency Medicine
Family Medicine
Forensic Medicine
Gynecology and Obstetrics
Histology and Embryology
History of Medicine
Human Genetics
Hygiene
Infectious Diseases
Internal Medicine
Medical Deontology and Philosophy
Medical Psychology
Microbiology and Immunology
Neurology
Occupational Medicine
Oncology
Ophthalmology
Orthopaedics
Otorhinolaryngology
Pathology
Pathophysiology
Pediatrics
Pharmacology and Experimental Toxicology
Physical and Rehabilitation Medicine
Physiology
Psychiatry
Radiology
Social Medicine
Surgery
Toxicology
Research papers
Clinical research paper
Preclinical research paper
Sponsored articles
Archive » 1998 » 2 » | Archive » Medical field » Fields » Human Genetics » Archive » Medical field » Research papers » Preclinical research paper »

The influence of alpha and beta fibrinogen genes’ polymorphisms on plasma fibrinogen level

 
Abstract:

This post is also available in: English Slovenščina (Slovenian)

Elevated plasma fibrinogen concen­tration is a risk factor for cardiovascular diseases. In addition to several factors such as advanced age, diabetes mellitus, cardiovascular disea­ses, elevated plasma cholesterol and glucose, and smoking, also genetic factors have been shown to influence plasma fibrinogen level. Stu­dies on influence of TaqI, HaeIII and BclI poly­morphisms on plasma fibrinogen concentration have shown contradictory results. Therefore, the influence of TaqI, HaeIII and BclI polymorp­hisms on plasma fibrinogen concentration was in­vestigated in healthy subjects from Slovenia. 143 healthy volunteers were included in the cross-sectional study. Fibrinogen values were determined with a clotting assay. Polymorphisms were detected by polymerase chain reaction and digestion with Taql, HaeIII and BclI restriction enzymes. Statistical analysis was performed with Student’s t-test, analysis of variance, χ² test and multiple regression analysis. ln all indi­viduals mean plasma fibrinogen concentration was 2.78 g/l (95% confidence interval 2.65–2.92 g/l), in smokers higher than in non-smo­kers (not significant; p = 0.40). Polymorphism TaqI was not associated with plasma fibrinogen level. There was a significant association between plasma fibrinogen concentration and HaeIII (p = 0.04) and BclI (p = 0.04) polymorphisms in the group of non-smokers. 5% of the plasma fibrino­gen variance in non-smokers could be attributed to the HaeIII polymorphism (p = 0.03). ln smokers, there was no association between HaeIII and BclI polymorphisms and plasma fibrinogen level.

Authors:
Steblovnik Lili

Keywords:
fibrinogen - blood - genetics, polymorphism (genetics), polymerase chain reaction

Cite as:
Med Razgl. 1998; 37: 155–72.

Download PDF >>
© 2024 Društvo Medicinski razgledi | Na vrh strani / To top ↑